Barbara Lavery, Chief Program Officer of Alliance for Cancer Gene Therapy, explains the funding priorities of ACGT. The non-profit organization funds innovative scientists and biotech companies working to harness the power of cell and gene therapy to transform cancer treatment. ACGT looks for the most promising cell and gene therapy research that can make it from laboratories to patients in clinical trials. Alliance for Cancer Gene Therapy also focuses on research for specific types of cancer, such as solid tumors like glioblastoma, lung cancer, ovarian cancer, prostate cancer, pancreatic cancer and many more.

свернуть